2016
DOI: 10.1021/acsami.6b03505
|View full text |Cite
|
Sign up to set email alerts
|

Acidic pH-Triggered Drug-Eluting Nanocomposites for Magnetic Resonance Imaging-Monitored Intra-arterial Drug Delivery to Hepatocellular Carcinoma

Abstract: Transcatheter hepatic intra-arterial (IA) injection has been considered as an effective targeted delivery technique for hepatocellular carcinoma (HCC). Recently, drug-eluting beads (DEB) were developed for transcatheter IA delivery to HCC. However, the conventional DEB has offered relatively modest survival benefits. It can be difficult to control drug loading/release from DEB and to monitor selective delivery to the targeted tumors. Embolized DEBs in hepatic arteries frequently induce hypoxic and low pH condi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

4
40
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 71 publications
(44 citation statements)
references
References 48 publications
(128 reference statements)
4
40
0
Order By: Relevance
“…The deposition of the Janus microcarriers in the rim region of tumor is further confirmed by the presence of iron in tissues stained with Prussian Blue (Figure b). The distribution of Janus microcarriers are good agreement with previous results of IA infused microspheres . The deposited Janus microcarriers in tumor‐feeding arteries permit a controlled release of drugs into the tumor blood vessels.…”
Section: Resultssupporting
confidence: 88%
See 1 more Smart Citation
“…The deposition of the Janus microcarriers in the rim region of tumor is further confirmed by the presence of iron in tissues stained with Prussian Blue (Figure b). The distribution of Janus microcarriers are good agreement with previous results of IA infused microspheres . The deposited Janus microcarriers in tumor‐feeding arteries permit a controlled release of drugs into the tumor blood vessels.…”
Section: Resultssupporting
confidence: 88%
“…For the magnetic anisotropy, iron oxide nanocubes with an average size of 27 nm are dispersed in the emulsion drops. The iron oxide nanocubes are synthesized by thermal decomposition of iron‐oleate complex in a mixture of sodium oleate, n ‐docosane, and 1‐octadecene and the surface is capped with oleic acid (Figure d and Figure S4, Supporting Information) . In addition, dual chemo agents of regorafenib and doxorubicin are dissolved in the emulsion drops.…”
Section: Resultsmentioning
confidence: 99%
“…The IONC loading efficacy within the IMM-MS was roughly 65%, which was consistent with our previous report. 19 As shown in Figure 2, IMM-MS exhibited much slower initial burst compared to control MS, whereas ~75% of IFN- γ was released from control MS in 1 h, IMM-MS released only ~27% of IFN- γ in 1 h. Furthermore, IMM-MS showed sustained drug release behavior over the entire test period. The sustained drug release behavior could be attributed to the water channel blocking by the addition of the iron oxide nanoparticles.…”
mentioning
confidence: 86%
“…The shape and the physicochemical properties were consistent with our previous paper. 19 Next, the as-synthesized iron oxide nanocubes and IFN- γ were coencapsulated in PLGA microspheres (i.e., IMM-MS) via a double emulsion method. Spherical-shaped microparticles were clearly observed with optical microscopy (Figure 1b).…”
mentioning
confidence: 99%
“…Therefore, it is urgent to inhibit tumor angiogenesis in the treatment of TACE. Sorafenib (SOR), a multi-target tyrosine kinase inhibitor with the ability to inhibit angiogenesis and tumor proliferation, and is the only Food and Drug Administration (FDA) approved drug for the treatment of advanced HCC [11]. However, due to the lack of tumor specificity, oral-systemic administration of sorafenib often leads to high toxicity and severe side effects [12].…”
mentioning
confidence: 99%